- Home
- BNGO vs BOLT Comparison
BNGO vs BOLT Comparison
Compare BNGO & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- BOLT
- Stock Information
- Founded
- BNGO 2003
- BOLT 2015
- Country
- BNGO United States
- BOLT United States
- Employees
- BNGO N/A
- BOLT N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- BNGO Industrials
- BOLT Health Care
- Exchange
- BNGO Nasdaq
- BOLT Nasdaq
- Market Cap
- BNGO 24.3M
- BOLT 22.6M
- IPO Year
- BNGO 2018
- BOLT 2021
- Fundamental
- Price
- BNGO $0.19
- BOLT $0.53
- Analyst Decision
- BNGO Hold
- BOLT Hold
- Analyst Count
- BNGO 3
- BOLT 5
- Target Price
- BNGO $1.00
- BOLT $1.25
- AVG Volume (30 Days)
- BNGO 16.7M
- BOLT 172.6K
- Earning Date
- BNGO 03-04-2025
- BOLT 03-20-2025
- Dividend Yield
- BNGO N/A
- BOLT N/A
- EPS Growth
- BNGO N/A
- BOLT N/A
- EPS
- BNGO N/A
- BOLT N/A
- Revenue
- BNGO $33,334,000.00
- BOLT $9,779,000.00
- Revenue This Year
- BNGO N/A
- BOLT $9.87
- Revenue Next Year
- BNGO $6.18
- BOLT N/A
- P/E Ratio
- BNGO N/A
- BOLT N/A
- Revenue Growth
- BNGO N/A
- BOLT 35.86
- 52 Week Low
- BNGO $0.17
- BOLT $0.48
- 52 Week High
- BNGO $1.36
- BOLT $1.56
- Technical
- Relative Strength Index (RSI)
- BNGO 39.40
- BOLT 45.96
- Support Level
- BNGO $0.17
- BOLT $0.50
- Resistance Level
- BNGO $0.26
- BOLT $0.59
- Average True Range (ATR)
- BNGO 0.05
- BOLT 0.04
- MACD
- BNGO -0.01
- BOLT -0.00
- Stochastic Oscillator
- BNGO 7.38
- BOLT 25.93
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.